Patents by Inventor Robert H. Stoffel

Robert H. Stoffel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Oxadiazole Compounds
    Publication number: 20110207704
    Abstract: Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the S1P family of G protein-coupled receptors for treating diseases associated with modulation of S1P family receptor activity, in particular by affording a beneficial immunosuppressive effect are disclosed.
    Type: Application
    Filed: August 24, 2010
    Publication date: August 25, 2011
    Applicant: ABBOTT LABORATORIES
    Inventors: Kevin P. Cusack, Eric C. Breinlinger, Shannon R. Fix-Stenzel, Robert H. Stoffel, Kevin R. Woller, Adrian D. Hobson, Pintipa Grongsaard
  • Oxadiazole compounds
    Patent number: 7834039
    Abstract: Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the S1P family of G protein-coupled receptors for treating diseases associated with modulation of S1P family receptor activity, in particular by affording a beneficial immunosuppressive effect are disclosed.
    Type: Grant
    Filed: December 14, 2007
    Date of Patent: November 16, 2010
    Assignee: Abbott Laboratories
    Inventors: Adrian D. Hobson, Shannon R. Fix-Stenzel, Kevin P. Cusack, Eric C. Breinlinger, Graham K. Ansell, Robert H. Stoffel, Kevin R. Woller, Pintipa Grongsaard
  • Novel therapeutic compounds
    Publication number: 20090069288
    Abstract: Disclosed herein are novel compounds of Formula (I), wherein the variables are defined as herein. The compounds of Formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases as well as proliferative disorders such as cancer.
    Type: Application
    Filed: July 15, 2008
    Publication date: March 12, 2009
    Inventors: Eric C. Breinlinger, Kevin P. Cusack, Adrian D. Hobson, Bin Li, Thomas D. Gordon, Robert H. Stoffel, Grier A. Wallace, Pintipa Grongsaard, Lu Wang, Lu Wang
  • Novel oxadiazole compounds
    Publication number: 20080280876
    Abstract: Novel oxadiazole compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions as agonists or antagonists of the S1P family of G protein-coupled receptors for treating diseases associated with modulation of S1P family receptor activity, in particular by affording a beneficial immunosuppressive effect are disclosed.
    Type: Application
    Filed: December 14, 2007
    Publication date: November 13, 2008
    Inventors: Adrian D. Hobson, Shannon R. Fix-Stenzel, Kevin P. Cusack, Eric C. Breinlinger, Graham K. Ansell, Robert H. Stoffel
  • NPY antagonists: spiroisoquinolinone derivatives
    Patent number: 6348472
    Abstract: A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of spiroisoquinolinone derivatives of Formula I. As antagonists of NPY-induced feeding behavior, these compounds and known analogs are expected to act as effective anorexiant agents in promoting weight loss and treating eating disorders.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: February 19, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventors: Graham S. Poindexter, Ildiko Antal, Leah M. Giupponi, Robert H. Stoffel, Marc A. Bruce
  • Imidazolone anorectic agents: II. phenyl derivatives
    Patent number: 6054590
    Abstract: A series of non-peptidergic antagonists of NPY have been synthesized and are comprised of phenyl derivatives of imidazolone compounds of Formula I. ##STR1## As antagonists of NPY-induced feeding behavior, these compounds and known analogs are expected to act as effective anorexiant agents in promoting weight loss and treating eating disorders.
    Type: Grant
    Filed: March 3, 1999
    Date of Patent: April 25, 2000
    Assignee: Bristol-Myers Squibb Company
    Inventors: Graham S. Poindexter, Ildiko Antal, Leah M. Giupponi, Robert H. Stoffel, Kevin Gillman, Mendi Higgins